|
|
| (One intermediate revision by one other user not shown) |
| Line 1: |
Line 1: |
| __NOTOC__
| | #REDIRECT [[Clonidine#Patient Counseling Information]] |
| {{Clonidine}}
| |
| {{CMG}}; {{AE}} {{PB}}
| |
| | |
| '''''For patient information, click [[Clonidine (patient information)|here]]'''''.
| |
| | |
| ==Patient Counseling Information==
| |
| | |
| | |
| Patients should be cautioned against interruption of CATAPRES tablets therapy without their physician's advice.
| |
| | |
| Since patients may experience a possible sedative effect, [[dizziness]], or accommodation disorder with use of clonidine, caution patients about engaging in activities such as driving a vehicle or operating appliances or machinery. Also, inform patients that this sedative effect may be increased by concomitant use of alcohol, [[barbiturates]], or other sedating drugs.
| |
| | |
| Patients who wear contact lenses should be cautioned that treatment with CATAPRES tablets may cause dryness of eyes.
| |
| | |
| <ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = CATAPRES (CLONIDINE HYDROCHLORIDE) TABLET [BOEHRINGER INGELHEIM PHARMACEUTICALS INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d7f569dc-6bed-42dc-9bec-940a9e6b090d | publisher = | date = | accessdate = 5 February 2014 }}</ref>
| |
| | |
| ==References==
| |
| | |
| {{Reflist|2}}
| |
| | |
| {{Antimigraine preparations}}
| |
|
| |
|
| | [[Category:Cardiovascular Drugs]] |
| [[Category:Drugs]] | | [[Category:Drugs]] |